RAFAEL HOLDINGS, INC. Line of Credit Facility, Interest Rate During Period
RAFAEL HOLDINGS, INC. (RFL) reported Line of Credit Facility, Interest Rate During Period of 37.50% for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for the quarter ending 2021-10-31 was 37.50%, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for the quarter ending 2021-04-30 was 37.50%.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for the quarter ending 2021-01-31 was 37.50%, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for the quarter ending 2020-10-31 was 37.50%, a 0.00% change year-over-year.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for fiscal 2022 was 37.50%, a 0.00% change from fiscal 2021.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for fiscal 2021 was 37.50%, a 0.00% change from fiscal 2020.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for fiscal 2020 was 37.50%, a 0.00% change from fiscal 2019.
- RAFAEL HOLDINGS, INC. line of credit facility, interest rate during period for fiscal 2019 was 37.50%.
| Period end | Line of Credit Facility, Interest Rate During Period 3 month | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 9 month | Line of Credit Facility, Interest Rate During Period 9 month as first filed | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|---|---|---|---|
| 2023-04-30 | 37.50% 10-Q · filed 2023-06-13 | ||||
| 2023-01-31 | 37.50% 10-Q · filed 2023-03-14 | ||||
| 2022-07-31 | 37.50% 10-K · filed 2023-10-30 | ||||
| 2021-10-31 | 37.50% 10-Q/A · filed 2022-02-28 | ||||
| 2021-07-31 | 37.50% 10-K · filed 2021-10-18 | ||||
| 2021-04-30 | 37.50% 10-Q · filed 2021-06-14 | 37.50% 10-Q · filed 2021-06-14 | |||
| 2021-01-31 | 37.50% 10-Q · filed 2021-03-17 | 37.50% 10-Q · filed 2021-03-17 | |||
| 2020-10-31 | 37.50% 10-Q · filed 2020-12-15 | ||||
| 2020-07-31 | 37.50% 10-K · filed 2021-10-18 | ||||
| 2020-04-30 | 9.00% 10-Q · filed 2021-06-14 | 37.50% 10-Q · filed 2020-06-09 | |||
| 2020-01-31 | 37.50% 10-Q · filed 2021-03-17 | 37.50% 10-Q · filed 2021-03-17 | |||
| 2019-10-31 | 37.50% 10-Q · filed 2020-12-15 | ||||
| 2019-07-31 | 37.50% 10-K · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |